QNTM
Quantum BioPharma Ltd.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$59.12M
P/E Ratio
—
EPS
$-7.73
Beta
0.36
52W High
$38.25
52W Low
$2.07
50-Day MA
$4.46
200-Day MA
$9.25
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Quantum BioPharma Ltd.
Quantum BioPharma Ltd. (QNTM) is an innovative biotechnology company focused on developing transformative therapies targeting oncology and autoimmune diseases. With a robust pipeline of biopharmaceutical products and a strong emphasis on research and development, Quantum leverages advanced technologies to address unmet medical needs. The company’s strategic collaborations and experienced leadership contribute to its competitive edge, positioning it well for growth in the dynamic biopharmaceutical landscape. As the market for novel therapeutics expands, QNTM presents an appealing investment opportunity for institutional investors seeking exposure in this high-potential sector.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-14.33M |
| Operating Margin | 0.00% |
| Return on Equity | -2057.00% |
| Return on Assets | -62.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.78 |
| Price-to-Book | 99.33 |
| Price-to-Sales (TTM) | 91.86 |
| EV/Revenue | 98.56 |
| EV/EBITDA | -1.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $6.40M |
| Float | $4.13M |
| % Insiders | 12.37% |
| % Institutions | 9.86% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026